Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease

被引:0
|
作者
Masaru Togashi
Takenori Niioka
Atsushi Komatsuda
Mizuho Nara
Shin Okuyama
Ayumi Omokawa
Maiko Abumiya
Hideki Wakui
Naoto Takahashi
Masatomo Miura
机构
[1] Akita University Graduate School of Medicine,Department of Hematology, Nephrology, Rheumatology
[2] Akita University Hospital,Department of Pharmacy
[3] Akita University Hospital,Center for Kidney Disease and Transplantation
[4] Akita University Graduate School of Medicine,Department of General Internal Medicine and Clinical Laboratory Medicine
[5] Akita University,Department of Life Science, Graduate School of Engineering and Resource Science
关键词
Itraconazole; Tacrolimus; polymorphism; Drug-drug interaction; Connective tissue disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1091 / 1097
页数:6
相关论文
共 50 条
  • [21] Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
    Wu, Li-hua
    Shentu, Jian-zhong
    Jin, Jing
    Yu, Song-feng
    Wang, Wei-lin
    Zheng, Shu-sen
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 228 - 228
  • [22] Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
    Jing, Jin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A203 - A204
  • [23] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [24] Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
    Ho, Teresa T.
    Perkins, Janelle B.
    Gonzalez, Rebecca
    Hicks, James Kevin
    Martinez, Ronald Alvarez
    Duranceau, Katie
    North, Brianna
    Kim, Jongphil
    Teer, Jamie K.
    Yao, Jiqiang
    Yoder, Sean J.
    Nishihori, Taiga
    Bejanyan, Nelli
    Pidala, Joseph
    Elmariah, Hany
    PHARMACOGENOMICS, 2024, 25 (01) : 29 - 40
  • [25] Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients
    Cusinato, Diego Alberto C.
    Lacchini, Riccardo
    Romao, Elen A.
    Moyses-Neto, Miguel
    Coelho, Eduardo B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 364 - 372
  • [26] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    T Vanhove
    P Annaert
    D Lambrechts
    D R J Kuypers
    The Pharmacogenomics Journal, 2017, 17 : 556 - 562
  • [27] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, T.
    Annaert, P.
    Lambrechts, D.
    Kuypers, D. R. J.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (06): : 556 - 562
  • [28] IMPACT OF CYP3A5, CYP3A4, AND ABCB1 GENOTYPES ON TACROLIMUS DOSING AND MONITORING IN LIVER TRANSPLANT PATIENTS
    Ladd, Alexandra
    Pahim, Isabella Angeli
    Warren, Curtis
    Duarte, Sergio
    Zarrinpar, Ali
    HEPATOLOGY, 2022, 76 : S1284 - S1285
  • [29] Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation
    Ling, Jing
    Dong, Lu-Lu
    Yang, Xu-Ping
    Qian, Qing
    Jiang, Yan
    Zou, Su-Lan
    Hu, Nan
    XENOBIOTICA, 2020, 50 (12) : 1501 - 1509
  • [30] Effect of the New Functional CYP3A4*22, CYP3A5 and ABCB1 Polymorphisms On the Tacrolimus Concentrations in Hispanic Kidney Transplant Recipients.
    Vu, D.
    Qwak, H.
    Sakharkar, P.
    Kim, J.
    Shah, T.
    Hutchinson, I.
    Naraghi, R.
    Min, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 888 - 889